Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

37 results about "Hyocholic acid" patented technology

Hyocholic acid or 3α,6α,7α-trihydroxy-5β-cholan-24-oic acid is a bile acid found as one of the main forms in pig, and at low concentrations in other species including humans.

Composition for predicting and curing treating type 2 diabetes mellitus, evaluation method and preparation of composition for predicting and treating type 2 diabetes mellitus

The invention provides a composition for predicting and curing treating type 2 diabetes mellitus, and an evaluation method and a preparation of the composition for predicting and treating type 2 diabetes mellitus. The composition is prepared from hyocholic acid, hyodeoxycholic acid, glycohyocholic acid, glycohyodeoxycholic acid, taurohyocholic acid, taurohyodeoxycholic acid, and a steroidal amidehyocholic acid derivative prepared fromformed byprepared from the hyocholic acid or the hyodeoxycholic acid and amino acids except for glycine and taurine. One of targets for a drug prepared from thecomposition is intestinal epithelial endocrine cells, through drug stimulation, a bile acid membrane receptor TGR5 can be excited, meanwhile, a bile acid nucleus receptor FXR is antagonized, the effects of stimulating the intestinal endocrine cells to secrete GLP1 is achieved jointly, and thus blood sugar is reduced; meanwhile, the content of the composition of a human body is detected, the futurediabetes mellitus risk can be predicted, diabetes mellitus can be screened or early detected, and the curing time is savedprolonged for patients; and the curing effect can also be evaluated by testing the content of the composition after curing.
Owner:SHENZHEN YUNHE PHARM TECH PARTNERSHIP LTD

Biomarker detection kit for cholestasis indication prognosis

The invention relates to a biomarker for cholestasis indication prognosis, a marker detection method and a corresponding kit. The prognosis indication biomarker is selected from one or more of glycyl acylated hyocholic acid (Glyco-hyoCA or GHCA), taurosylated-2 [beta], 3 [alpha], 7 [alpha], 12 [alpha]-tetrahydroxycholic acid (Tauro-2 [beta], 3 [alpha], 7 [alpha], 12 [alpha]-Tetraphydroxy bileacid or Tauro-2 [beta], 3 [alpha], 7 [alpha], 12 [alpha]-THBA),taurosylated hyocholic acid (Tauro-hyoCA or THCA), Tauro-3 [alpha], 6 [beta], 7 [alpha], 12 [alpha]-THBA, Tauro-3 [alpha], 6 [alpha], 7 [alpha], 12 [alpha]-THBA, and total Tauro-THBAs. The detection finds that bile acid spectrums in serum/plasma samples of subjects are concentrated, different bile acids are screened out to serve as candidate indication prognosis markers, meanwhile, corresponding cutoff values are formulated, and the cutoff values are applied to a verification set to verify the indication prognosis efficiency of the verification set. The invention provides the method and the kit for prognosis judgment of cholestasis for the first time, the detection efficiency is high, the result is accurate, the method and the kit are suitable for early prognosis effect judgment of patients with cholestasis, and guidance is provided for individual treatment and medication schemes.
Owner:CHILDRENS HOSPITAL OF FUDAN UNIV +1

7-ketone lithocholic acid intermediate, preparation method and applications thereof

ActiveCN110437296AThe reaction conditions are mild and not harshImprove securitySteroidsBulk chemical productionCholic acidLeaving group
The invention discloses a 7-ketone lithocholic acid intermediate, a preparation method and applications thereof. The preparation method comprises: carrying out an esterification reaction on hyocholicacid as a starting raw material; adding 2,2-dimethylpropane to carry out a reaction with the unique 6,7 synclastic hydroxyl structure to form cross protection; selectively protecting the 3-site hydroxyl group; selectively linking the leaving group to the 6-site to form a 7-ketone lithocholic acid intermediate by using the special spatial structure of hyocholic acid; selectively oxidizing the unique 7-site exposed hydroxyl group of the 7-ketone lithocholic acid intermediate to form an alpha hydroxyketone intermediate with a leaving group linked to the 6-site; simultaneously and directly removing the 6-site hydroxyl group and the leaving group by using the hydroxyketone to form an intermediate 7; and removing the protection group through simple hydrolysis of the intermediate 7 to obtain the7-ketone lithocholic acid. According to the present invention, the 7-ketone lithocholic acid prepared by the method has high purity, and the method has characteristics of simple process and no specialpurification method, and is suitable for industrial production.
Owner:成都百途医药科技有限公司

7-ketolithocholic acid intermediate and its preparation method and application

The invention discloses a 7-ketolithocholic acid intermediate and its preparation method and application. The invention uses hyocholic acid as a starting material, first performs esterification reaction, and then adds 2,2-dimethylpropane and hyocholic acid The unique 6,7 hydroxyl structure reacts to form parallel fork protection, and then selectively protects the 3-position hydroxyl group, and then uses the special space structure of hyocholic acid to selectively connect the leaving group to the 6-position to form 7-ketone Keystone cholic acid intermediate, 7-ketolithocholic acid intermediate unique 7-position exposed hydroxyl group, selective oxidation of 7-position hydroxyl group to form α-hydroxy ketone intermediate 6 with 6-position connecting leaving group, this type of hydroxyketone can be directly The hydroxyl group at the 6th position and the leaving group are removed simultaneously to form intermediate 7, and intermediate 7 can be deprotected by simple hydrolysis to obtain the target product 7-ketolithocholic acid. The 7-ketolithocholic acid prepared by the method of the present invention not only has high purity, but also has a simple process flow and no special purification method in the preparation process, which is suitable for industrial production.
Owner:成都百途医药科技有限公司

A method for extracting chenodeoxycholic acid and allocholic acid from duck bile

ActiveCN106749473BRealize refining and purificationHigh extraction rateSteroidsAlkaneChenodeoxycholic acid
The invention discloses a method for extracting chenodeoxycholic acid and allocholic acid from duck bile, and belongs to the technical field of biological engineering. The method comprises the following steps of (1) preparing of bile acid extracting liquid: obtaining duck bile, saponifying, cooling, adjusting a pH (potential of hydrogen) value to 7 to 8, adding a mixed solvent of ester and alkane, adjusting the pH value to 2 to 4, extracting, and discoloring, so as to obtain the bile acid extracting liquid; (2) preparing of bile acid magnesium salt: adjusting the pH value of the bile acid extracting liquid in step (1) to 4.5 to 5.5, dissolving the magnesium salt, adding into the bile acid extracting liquid, refluxing, cooling, and separating, so as to respectively obtain the magnesium allocholate and a chenodeoxycholic acid solution; refining and purifying the chenodeoxycholic acid solution, so as to obtain a finished product of henodeoxycholic acid; (3) extracting of the allocholic acid: adding water and carbonate into the prepared magnesium allocholate in step (2), heating and dissolving, separating solid from liquid, adjusting the pH value of a solution to 1 to 2, and separating solid from liquid, so as to obtain a finished product of the allocholic acid. The method has the advantages that the purities and extracting rates of the chenodeoxycholic acid and the allocholic acid are greatly improved, the operation is safe, and the method is suitable for industrialization.
Owner:CHANGDE YUNGANG BIOTECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products